Go Pro
→ My top 3 AI picks for the next decade (From The Oxford Club) (Ad)tc pixel Free OCGN Stock Alerts

Ocugen (OCGN) News Today

Ocugen logo
$1.06 +0.03 (+2.91%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$1.06 -0.01 (-0.47%)
As of 09/18/2026 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Ocugen Latest News

Ocugen Targets Three Gene Therapy BLA Filings as Retinal Pipeline Advances
September 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/event-ocugen-targets-three-gene-therapy-bla-filings-as-retinal-pipeline-advances-2026-09-15/
What is HC Wainwright's Forecast for Ocugen FY2028 Earnings?
September 14, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31021687
What is HC Wainwright's Estimate for Ocugen FY2028 Earnings?
September 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/estimates-what-is-hc-wainwrights-estimate-for-ocugen-fy2028-earnings-2026-09-14/
What is HC Wainwright's Forecast for Ocugen FY2029 Earnings?
September 13, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31019786
Ocugen (NASDAQ:OCGN) CEO Shankar Musunuri Sells 468,727 Shares of Stock
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/insider-ocugen-nasdaq-ocgn-ceo-shankar-musunuri-sells-468727-shares-of-stock-2026-09-11/
Ocugen: Q3 Data Catalyst In Stargardt Disease Feels Critical
September 11, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4945553-ocugen-q3-data-catalyst-in-stargardt-disease-feels-critical
What is HC Wainwright's Estimate for Ocugen FY2029 Earnings?
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/estimates-what-is-hc-wainwrights-estimate-for-ocugen-fy2029-earnings-2026-09-11/
Ocugen: My Hold Rating Continued On OCU410ST Advancement And Upcoming Catalysts
September 10, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4945149-ocugen-my-hold-rating-continued-on-ocu410st-advancement-and-upcoming-catalysts
What's Happening With Ocugen Stock Thursday?
September 10, 2026  |  benzinga.comhttps://www.benzinga.com/trading-ideas/movers/26/09/61713486/whats-happening-with-ocugen-stock-thursday?utm_source=snapi
Ocugen slips after interim trial data for Stargardt disease candidate
September 9, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4641296-ocugen-slips-stargardt-disease-trial-data
Ocugen, Inc. (OCGN) Stock Price, News, Quote & History - Yahoo Finance
September 9, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/quote/OCGN/latest-news/
Ocugen, Inc. (NASDAQ:OCGN) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
September 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-ocugen-inc-nasdaq-ocgn-receives-consensus-recommendation-of-moderate-buy-from-brokerages-2026-09-08/
Bank of America Corp DE Grows Stock Position in Ocugen, Inc. $OCGN
September 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-america-corp-de-grows-stock-position-in-ocugen-inc-ocgn-2026-09-03/
OCGN Advances Gene Therapy OCU410 In Phase III for Geographic Atrophy
September 2, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/ocgn-advances-gene-therapy-ocu410-145200805.html
Ocugen Eases on Tests
September 1, 2026  |  baystreet.cahttps://www.baystreet.ca/stockstowatch/23969/Ocugen-Eases-on-Tests
Ocugen Doses First Patient in Global Phase 3 ArMaDa3 Trial of OCU410 for Geographic Atrophy and Receives FDA RMAT Designation
September 1, 2026  |  quiverquant.comQ
Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
September 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/01/3353979/0/en/ocugen-announces-first-patient-dosed-in-phase-3-registrational-trial-of-ocu410-modifier-gene-therapy-for-geographic-atrophy-secondary-to-dry-age-related-macular-degeneration.html
27,002,933 Shares in Ocugen, Inc. $OCGN Acquired by BlackRock Inc.
September 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-27002933-shares-in-ocugen-inc-ocgn-acquired-by-blackrock-inc-2026-09-01/
Ocugen, Inc. (OCGN) Stock Earnings Call Transcripts - Yahoo Finance
August 28, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/quote/OCGN/earnings-calls/
Ocugen to Participate in Upcoming September Investor and Industry Conferences
August 25, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/ocugen-participate-upcoming-september-investor-110200614.html
Ocugen to Present Modifier Gene Therapy Platform at Upcoming Investor and Industry Conferences in September 2026
August 25, 2026  |  quiverquant.comQ
Ocugen to Participate in Upcoming September Investor and Industry Conferences
August 25, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/25/3350323/0/en/ocugen-to-participate-in-upcoming-september-investor-and-industry-conferences.html
Ocugen (OCGN) Q2 2026 Earnings Call Transcript
August 13, 2026  |  fool.comhttps://www.fool.com/earnings/call-transcripts/2026/08/13/ocugen-ocgn-q2-2026-earnings-call-transcript/
Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX) and Ocugen (OCGN)
August 11, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/3771617/analysts-offer-insights-on-healthcare-companies-protagonist-therapeutics-ptgx-and-ocugen-ocgn/
Ocugen (OCGN) Receives a Buy from Noble Financial
August 8, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/3736571/ocugen-ocgn-receives-a-buy-from-noble-financial/
Ocugen's Q2 Earnings Miss Estimates as R&D Costs Rise, Stock Falls
August 7, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/ocugens-q2-earnings-miss-estimates-171800453.html
Ocugen targets 3 BLAs by 2028 as FDA clears OCU410 Phase III and cash runway extends into 2028
August 7, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4628517-ocugen-targets-3-blas-by-2028-as-fda-clears-ocu410-phase-iii-and-cash-runway-extends-into
Ocugen Inc (OCGN) (Q2 2026) Earnings Call Highlights: FDA Clearance for OCU410 Phase 3 Trial ...
August 6, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/ocugen-inc-ocgn-q2-2026-231546451.html
Ocugen (OCGN) Reports Q2 Loss, Beats Revenue Estimates
August 6, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/ocugen-ocgn-reports-q2-loss-135008498.html
Ocugen Reports Q2 2026 Results, Advances OCU410 Phase 3, Secures RMAT Designation and $130 Million Financing
August 6, 2026  |  quiverquant.comQ
Ocugen Provides Business Update with Second Quarter 2026 Financial Results
August 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/06/3340127/0/en/ocugen-provides-business-update-with-second-quarter-2026-financial-results.html
Ocugen to Participate in Upcoming August Investor Conferences
July 31, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/ocugen-participate-upcoming-august-investor-110200107.html
Ocugen to Present Modifier Gene Therapy Platform at Upcoming August 2026 Investor Conferences
July 31, 2026  |  quiverquant.comQ
Ocugen to Participate in Upcoming August Investor Conferences
July 31, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/31/3336726/0/en/ocugen-to-participate-in-upcoming-august-investor-conferences.html
Ocugen Announces that the U.S. Food and Drug Administration Has Granted OCU410 Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Geographic Atrophy ...
July 29, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/ocugen-announces-that-the-u-s-food-and-drug-administration-has-granted-ocu410-regenerative-medicine-advanced-therapy-rmat-designation-for-treatment-of-geographic-atrophy-secondary-to-dry-1036377643
Ocugen Announces that the U.S. Food and Drug Administration Has Granted OCU410 Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Geographic Atrophy, Secondary to Dry Age-Related Macular Degeneration
July 29, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/ocugen-announces-u-food-drug-110100124.html
Ocugen Announces that the U.S. Food and Drug Administration Has Granted OCU410 Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Geographic Atrophy, Secondary to Dry Age-Related Macular Degeneration
July 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/29/3335110/0/en/ocugen-announces-that-the-u-s-food-and-drug-administration-has-granted-ocu410-regenerative-medicine-advanced-therapy-rmat-designation-for-treatment-of-geographic-atrophy-secondary-.html
Ocugen to Host Conference Call on Thursday, August 6 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2026 Financial Results
July 28, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/ocugen-host-conference-call-thursday-200100334.html
Ocugen to Host Conference Call on Thursday, August 6 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2026 Financial Results
July 28, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/28/3334691/0/en/ocugen-to-host-conference-call-on-thursday-august-6-at-8-30-a-m-et-to-discuss-business-updates-and-second-quarter-2026-financial-results.html
Ocugen signs OCU400 licensing term sheet
July 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4613147-ocugen-signs-ocu400-licensing-term-sheet
Ocugen, Inc. Announces Binding Term Sheet with Roots Pharmaceutical to License OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa
July 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/13/3326081/0/en/ocugen-inc-announces-binding-term-sheet-with-roots-pharmaceutical-to-license-ocu400-modifier-gene-therapy-for-retinitis-pigmentosa-in-the-middle-east-and-north-africa.html
Ocugen to Participate in Upcoming July Industry Conferences
July 1, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/ocugen-participate-upcoming-july-industry-110000950.html
Ocugen to Participate in Upcoming July Industry Conferences
July 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/01/3320487/0/en/ocugen-to-participate-in-upcoming-july-industry-conferences.html
Ocugen: Financing Risk Is Lower, But The Clinical Bet Still Has To Work
June 25, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4917566-ocugen-stock-financing-risk-is-lower-but-the-clinical-bet-still-has-to-work
Ocugen (OCGN) Stock Draws Fresh Price Target Split After Cautious Analyst View
June 24, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/ocugen-ocgn-stock-draws-fresh-002301846.html
Ocugen Inc. stock rises Tuesday, outperforms market
June 24, 2026  |  marketwatch.comhttps://www.marketwatch.com/data-news/ocugen-inc-stock-rises-tuesday-outperforms-market-8bd1f3da-57de3fb90135
Ocugen (NASDAQ:OCGN) CFO Treerita Essali Johnson-Greene Acquires 21,000 Shares
June 18, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-ocgn-insider-buying-and-selling-2026-06-18/
How The Ocugen (OCGN) Investment Story Is Evolving Without New Analyst Guidance
June 5, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/ocugen-ocgn-investment-story-evolving-010537704.html
Why Is Ocugen (OCGN) Down 10.7% Since Last Earnings Report?
June 4, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/why-ocugen-ocgn-down-10-153023378.html
Ocugen Consolidates Financial Leadership Under New Accounting Officer
June 3, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/ocugen-consolidates-financial-leadership-under-new-accounting-officer?utm_source=marketbeat.com&utm_medium=referral

Ocugen Media Mentions By Week

Ocugen Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

OCGN
News Sentiment
▼
-0.12

0.56
▲
Average
Healthcare
News Sentiment

Ocugen News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

OCGN Articles
This Week
▼
4

5
▲
OCGN Articles
Average Week

Ocugen Trends on MarketBeat

This week vs. last week
New Followers
2
+100%
Searches
4
-33%
Page Views
4,493
+1%
Get Ocugen News Delivered to You Automatically

Sign up to receive the latest news and ratings for OCGN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
News and Trends Tools

MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Ocugen dated 9/15/2026.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel